Evidence map›Paper›PMID 25606410›Full record

ArticleMeta gene2014

De novo 393 kb microdeletion of 7p11.2 characterized by aCGH in a boy with psychomotor retardation and dysmorphic features.

Konstantinos Varvagiannis, Ioannis Papoulidis, Theodora Koromila, Konstantinos Kefalas, Monika Ziegler, Thomas Liehr, Michael B Petersen, Yolanda Gyftodimou, Emmanouil Manolakos

Open access · hybridAbstract read
In one paragraph

Article in Meta gene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Human Mitoribosome Biogenesis and Its Emerging Links to Disease.International journal of molecular sciences · 2021
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Konstantinos VarvagiannisDepartment of Genetics, Institute of Child Health, Athens, Greece.
Ioannis PapoulidisEurogenetica S.A., Laboratory of Genetics, Athens-Thessaloniki, Greece.
Theodora KoromilaLaboratory of Human Genetics, Department of Biology, University of Athens, Athens, Greece.
Konstantinos KefalasBioiatriki S.A., Laboratory of Genetics, Athens, Greece.
Monika ZieglerInstitute of Human Genetics Anthropology, Jena University Hospital, Jena, Germany.
Thomas LiehrInstitute of Human Genetics Anthropology, Jena University Hospital, Jena, Germany.
Michael B PetersenDepartment of Genetics, Institute of Child Health, Athens, Greece.
Yolanda GyftodimouDepartment of Genetics, Institute of Child Health, Athens, Greece.
Emmanouil ManolakosEurogenetica S.A., Laboratory of Genetics, Athens-Thessaloniki, Greece ; Cattedra di Genetica Medica, Ospedale Binaghi, Cagliari, Italy.
Institute of Child Health · GRJena University Hospital · DEEuromedica · GRNational and Kapodistrian University of Athens · GROspedale degli Infermi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on a 27 month old boy presenting with psychomotor delay and dysmorphic features, mainly mild facial asymmetry, prominent cup-shaped ears, long eyelashes, open mouth appearance and slight abnormalities of the hands and feet. Array comparative genomic hybridization revealed a 393 kb microdeletion in 7p11.2. We discuss the possible involvement of CHCHD2, GBAS, MRPS17, SEPT14 and PSPH on our patient's phenotype. Additionally, we studied the expression of two other genes deleted in the patient, CCT6A and SUMF2, for which there is scarce data in the literature. Based on current knowledge and the de novo occurrence of this finding in our proband we presume that the aberration is likely to be pathogenic in our case. However, a single gene disorder, elsewhere in the genome or in this very region cannot be ruled out. Further elucidation of the properties of this chromosomal region, as well as of the role of the genes involved will be needed in order to draw safe conclusions regarding the association of the chromosomal deletion with the patient's features.

Indexed as

CCT6ACHCHD2Deletion 7p11.2Dysmorphic featuresGBASMRPS17PSPHPsychomotor delaySEPT14SUMF2

Identifiers

PMID25606410
PMCPMC4287824
OpenAlexW1973791536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.